ID   SC6A4_RAT               Reviewed;         630 AA.
AC   P31652; P23976;
DT   01-JUL-1993, integrated into UniProtKB/Swiss-Prot.
DT   01-JUL-1993, sequence version 1.
DT   02-OCT-2024, entry version 179.
DE   RecName: Full=Sodium-dependent serotonin transporter;
DE            Short=SERT {ECO:0000303|PubMed:16870614};
DE   AltName: Full=5HT transporter;
DE            Short=5HTT;
DE   AltName: Full=Solute carrier family 6 member 4;
GN   Name=Slc6a4;
OS   Rattus norvegicus (Rat).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Glires; Rodentia; Myomorpha; Muroidea; Muridae;
OC   Murinae; Rattus.
OX   NCBI_TaxID=10116;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Wistar;
RX   PubMed=1765155; DOI=10.1016/0014-5793(91)81418-8;
RA   Mayser W., Betz H., Schloss P.;
RT   "Isolation of cDNAs encoding a novel member of the neurotransmitter
RT   transporter gene family.";
RL   FEBS Lett. 295:203-206(1991).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, TISSUE SPECIFICITY, TRANSPORTER
RP   ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RC   TISSUE=Brain stem;
RX   PubMed=1944572; DOI=10.1038/354066a0;
RA   Blakely R.D., Berson H.E., Fremeau R.T. Jr., Caron M.G., Peek M.M.,
RA   Prince H.K., Bardley C.C.;
RT   "Cloning and expression of a functional serotonin transporter from rat
RT   brain.";
RL   Nature 354:66-70(1991).
RN   [3]
RP   SEQUENCE REVISION.
RA   Blakely R.D.;
RL   Submitted (JUL-1992) to the EMBL/GenBank/DDBJ databases.
RN   [4]
RP   NUCLEOTIDE SEQUENCE [MRNA], FUNCTION, SUBCELLULAR LOCATION, AND TRANSPORTER
RP   ACTIVITY.
RX   PubMed=1948036; DOI=10.1126/science.1948036;
RA   Hoffman B.J., Mezey E., Brownstein M.J.;
RT   "Cloning of a serotonin transporter affected by antidepressants.";
RL   Science 254:579-580(1991).
RN   [5]
RP   NUCLEOTIDE SEQUENCE [MRNA].
RC   STRAIN=Fawn hooded;
RA   Gonzalez A.M., Smith A.P.L., Emery C.J., Higenbottam T.W.;
RL   Submitted (FEB-1997) to the EMBL/GenBank/DDBJ databases.
RN   [6]
RP   FUNCTION, AND MUTAGENESIS OF ASN-177.
RX   PubMed=8968583; DOI=10.1016/s0006-3495(96)79506-1;
RA   Lin F., Lester H.A., Mager S.;
RT   "Single-channel currents produced by the serotonin transporter and analysis
RT   of a mutation affecting ion permeation.";
RL   Biophys. J. 71:3126-3135(1996).
RN   [7]
RP   FUNCTION, TRANSPORTER ACTIVITY, TISSUE SPECIFICITY, AND SUBCELLULAR
RP   LOCATION.
RC   TISSUE=Intestinal mucosa;
RX   PubMed=8601815; DOI=10.1523/jneurosci.16-07-02352.1996;
RA   Wade P.R., Chen J., Jaffe B., Kassem I.S., Blakely R.D., Gershon M.D.;
RT   "Localization and function of a 5-HT transporter in crypt epithelia of the
RT   gastrointestinal tract.";
RL   J. Neurosci. 16:2352-2364(1996).
RN   [8]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=10407194; DOI=10.1016/s0169-328x(99)00178-3;
RA   Mortensen O.V., Kristensen A.S., Rudnick G., Wiborg O.;
RT   "Molecular cloning, expression and characterization of a bovine serotonin
RT   transporter.";
RL   Brain Res. Mol. Brain Res. 71:120-126(1999).
RN   [9]
RP   MUTAGENESIS OF CYS-109 AND ILE-172, FUNCTION, SUBCELLULAR LOCATION,
RP   SUBUNIT, AND TRANSPORTER ACTIVITY.
RX   PubMed=10716733; DOI=10.1073/pnas.97.7.3106;
RA   Kilic F., Rudnick G.;
RT   "Oligomerization of serotonin transporter and its functional
RT   consequences.";
RL   Proc. Natl. Acad. Sci. U.S.A. 97:3106-3111(2000).
RN   [10]
RP   INTERACTION WITH STX1A, AND SUBCELLULAR LOCATION.
RX   PubMed=11709063; DOI=10.1042/0300-5127:0290722;
RA   Haase J., Killian A.M., Magnani F., Williams C.;
RT   "Regulation of the serotonin transporter by interacting proteins.";
RL   Biochem. Soc. Trans. 29:722-728(2001).
RN   [11]
RP   RETRACTED PAPER.
RX   PubMed=12944413; DOI=10.1074/jbc.m306360200;
RA   Ozaslan D., Wang S., Ahmed B.A., Kocabas A.M., McCastlain J.C., Bene A.,
RA   Kilic F.;
RT   "Glycosyl modification facilitates homo- and hetero-oligomerization of the
RT   serotonin transporter. A specific role for sialic acid residues.";
RL   J. Biol. Chem. 278:43991-44000(2003).
RN   [12]
RP   FUNCTION, INTERACTION WITH STX1A, AND MUTAGENESIS OF 14-GLU--GLU-23.
RX   PubMed=14642278; DOI=10.1016/s0896-6273(03)00605-6;
RA   Quick M.W.;
RT   "Regulating the conducting states of a mammalian serotonin transporter.";
RL   Neuron 40:537-549(2003).
RN   [13]
RP   INTERACTION WITH ITGB3.
RX   PubMed=18317590; DOI=10.1172/jci33374;
RA   Carneiro A.M., Cook E.H., Murphy D.L., Blakely R.D.;
RT   "Interactions between integrin alphaIIbbeta3 and the serotonin transporter
RT   regulate serotonin transport and platelet aggregation in mice and humans.";
RL   J. Clin. Invest. 118:1544-1552(2008).
RN   [14]
RP   FUNCTION, TRANSPORTER ACTIVITY, AND MUTAGENESIS OF ASN-101; SER-277 AND
RP   SER-404.
RX   PubMed=21730057; DOI=10.1074/jbc.m111.250308;
RA   Henry L.K., Iwamoto H., Field J.R., Kaufmann K., Dawson E.S., Jacobs M.T.,
RA   Adams C., Felts B., Zdravkovic I., Armstrong V., Combs S., Solis E. Jr.,
RA   Rudnick G., Noskov S.Y., DeFelice L.J., Meiler J., Blakely R.D.;
RT   "A conserved asparagine residue in transmembrane segment 1 (TM1) of
RT   serotonin transporter dictates chloride-coupled neurotransmitter
RT   transport.";
RL   J. Biol. Chem. 286:30823-30836(2011).
RN   [15]
RP   RETRACTION NOTICE OF PUBMED:12944413.
RX   PubMed=31201245; DOI=10.1074/jbc.w119.009466;
RA   Ozaslan D., Wang S., Ahmed B.A., Kocabas A.M., McCastlain J.C., Bene A.,
RA   Kilic F.;
RT   "Withdrawal: Glycosyl modification facilitates homo- and hetero-
RT   oligomerization of the serotonin transporter: a specific role for sialic
RT   acid residues.";
RL   J. Biol. Chem. 294:9657-9657(2019).
RN   [16]
RP   FUNCTION, SUBCELLULAR LOCATION, INTERACTION WITH FILAMENTOUS ACTIN,
RP   TRANSPORTER ACTIVITY, AND BIOPHYSICOCHEMICAL PROPERTIES.
RX   PubMed=15627510; DOI=10.1016/j.neuint.2004.08.008;
RA   Mochizuki H., Amano T., Seki T., Matsubayashi H., Mitsuhata C., Morita K.,
RA   Kitayama S., Dohi T., Mishima H.K., Sakai N.;
RT   "Role of C-terminal region in the functional regulation of rat serotonin
RT   transporter (SERT).";
RL   Neurochem. Int. 46:93-105(2005).
RN   [17]
RP   INTERACTION WITH SCAMP2, AND SUBCELLULAR LOCATION.
RX   PubMed=16870614; DOI=10.1074/jbc.m602848200;
RA   Mueller H.K., Wiborg O., Haase J.;
RT   "Subcellular redistribution of the serotonin transporter by secretory
RT   carrier membrane protein 2.";
RL   J. Biol. Chem. 281:28901-28909(2006).
RN   [18]
RP   PHOSPHORYLATION AT THR-276.
RX   PubMed=17310063; DOI=10.1074/jbc.m611353200;
RA   Ramamoorthy S., Samuvel D.J., Buck E.R., Rudnick G., Jayanthi L.D.;
RT   "Phosphorylation of threonine residue 276 is required for acute regulation
RT   of serotonin transporter by cyclic GMP.";
RL   J. Biol. Chem. 282:11639-11647(2007).
CC   -!- FUNCTION: Serotonin transporter that cotransports serotonin with one
CC       Na(+) ion in exchange for one K(+) ion and possibly one proton in an
CC       overall electroneutral transport cycle. Transports serotonin across the
CC       plasma membrane from the extracellular compartment to the cytosol thus
CC       limiting serotonin intercellular signaling (By similarity)
CC       (PubMed:10407194, PubMed:10716733, PubMed:15627510, PubMed:1944572,
CC       PubMed:1948036, PubMed:21730057, PubMed:8601815). Essential for
CC       serotonin homeostasis in the central nervous system. In the developing
CC       somatosensory cortex, acts in glutamatergic neurons to control
CC       serotonin uptake and its trophic functions accounting for proper
CC       spatial organization of cortical neurons and elaboration of sensory
CC       circuits. In the mature cortex, acts primarily in brainstem raphe
CC       neurons to mediate serotonin uptake from the synaptic cleft back into
CC       the pre-synaptic terminal thus terminating serotonin signaling at the
CC       synapse. Modulates mucosal serotonin levels in the gastrointestinal
CC       tract through uptake and clearance of serotonin in enterocytes.
CC       Required for enteric neurogenesis and gastrointestinal reflexes (By
CC       similarity). Regulates blood serotonin levels by ensuring rapid high
CC       affinity uptake of serotonin from plasma to platelets, where it is
CC       further stored in dense granules via vesicular monoamine transporters
CC       and then released upon stimulation (By similarity). Mechanistically,
CC       the transport cycle starts with an outward-open conformation having
CC       Na1(+) and Cl(-) sites occupied. The binding of a second extracellular
CC       Na2(+) ion and serotonin substrate leads to structural changes to
CC       outward-occluded to inward-occluded to inward-open, where the Na2(+)
CC       ion and serotonin are released into the cytosol. Binding of
CC       intracellular K(+) ion induces conformational transitions to inward-
CC       occluded to outward-open and completes the cycle by releasing K(+)
CC       possibly together with a proton bound to Asp-98 into the extracellular
CC       compartment. Na1(+) and Cl(-) ions remain bound throughout the
CC       transport cycle (By similarity) (PubMed:10407194, PubMed:10716733,
CC       PubMed:15627510, PubMed:1944572, PubMed:1948036, PubMed:21730057,
CC       PubMed:8601815). Additionally, displays serotonin-induced channel-like
CC       conductance for monovalent cations, mainly Na(+) ions. The channel
CC       activity is uncoupled from the transport cycle and may contribute to
CC       the membrane resting potential or excitability (PubMed:14642278,
CC       PubMed:8968583). {ECO:0000250|UniProtKB:P31645,
CC       ECO:0000250|UniProtKB:Q60857, ECO:0000269|PubMed:10407194,
CC       ECO:0000269|PubMed:10716733, ECO:0000269|PubMed:14642278,
CC       ECO:0000269|PubMed:15627510, ECO:0000269|PubMed:1944572,
CC       ECO:0000269|PubMed:1948036, ECO:0000269|PubMed:21730057,
CC       ECO:0000269|PubMed:8601815, ECO:0000269|PubMed:8968583}.
CC   -!- CATALYTIC ACTIVITY:
CC       Reaction=H(+)(in) + K(+)(in) + Na(+)(out) + serotonin(out) = H(+)(out)
CC         + K(+)(out) + Na(+)(in) + serotonin(in); Xref=Rhea:RHEA:75839,
CC         ChEBI:CHEBI:15378, ChEBI:CHEBI:29101, ChEBI:CHEBI:29103,
CC         ChEBI:CHEBI:350546; Evidence={ECO:0000269|PubMed:10407194,
CC         ECO:0000269|PubMed:10716733, ECO:0000269|PubMed:15627510,
CC         ECO:0000269|PubMed:1944572, ECO:0000269|PubMed:1948036,
CC         ECO:0000269|PubMed:21730057, ECO:0000269|PubMed:8601815};
CC       PhysiologicalDirection=left-to-right; Xref=Rhea:RHEA:75840;
CC         Evidence={ECO:0000305|PubMed:10407194, ECO:0000305|PubMed:10716733,
CC         ECO:0000305|PubMed:15627510, ECO:0000305|PubMed:1944572,
CC         ECO:0000305|PubMed:1948036, ECO:0000305|PubMed:21730057,
CC         ECO:0000305|PubMed:8601815};
CC   -!- BIOPHYSICOCHEMICAL PROPERTIES:
CC       Kinetic parameters:
CC         KM=0.29 uM for serotonin {ECO:0000269|PubMed:10407194};
CC         KM=21 uM for serotonin {ECO:0000269|PubMed:15627510};
CC         Vmax=12 pmol/min/mg enzyme for serotonin
CC         {ECO:0000269|PubMed:10407194};
CC   -!- SUBUNIT: Monomer or homooligomer (PubMed:10716733). Interacts with
CC       TGFB1I1. Interacts with SEC23A, SEC24C and PATJ. Interacts with NOS1;
CC       the interaction may diminish the cell surface localization of SERT in
CC       the brain and, correspondingly, reduce serotonin reuptake (By
CC       similarity). Interacts (via C-terminus) with SCAMP2; the interaction is
CC       direct and retains transporter molecules intracellularly
CC       (PubMed:16870614). Interacts with filamentous actin and STX1A
CC       (PubMed:11709063). Interacts (via the N-terminus) with STX1A (via the
CC       H3 domain); this interaction regulates SLC4A6 channel conductance
CC       (PubMed:11709063, PubMed:14642278). Interacts with ITGAV:ITGB3 (By
CC       similarity). Interacts (via C-terminus) with ITGB3; this interaction
CC       regulates SLC6A4 trafficking (By similarity).
CC       {ECO:0000250|UniProtKB:P31645, ECO:0000250|UniProtKB:Q60857,
CC       ECO:0000269|PubMed:10716733, ECO:0000269|PubMed:11709063,
CC       ECO:0000269|PubMed:14642278, ECO:0000269|PubMed:16870614}.
CC   -!- SUBCELLULAR LOCATION: Cell membrane {ECO:0000269|PubMed:11709063,
CC       ECO:0000269|PubMed:15627510, ECO:0000269|PubMed:16870614,
CC       ECO:0000269|PubMed:1948036, ECO:0000269|PubMed:8601815}; Multi-pass
CC       membrane protein {ECO:0000255}. Endomembrane system
CC       {ECO:0000269|PubMed:16870614}; Multi-pass membrane protein
CC       {ECO:0000255}. Endosome membrane {ECO:0000269|PubMed:16870614}; Multi-
CC       pass membrane protein {ECO:0000255}. Synapse
CC       {ECO:0000250|UniProtKB:Q60857}. Cell junction, focal adhesion
CC       {ECO:0000250|UniProtKB:Q60857}. Cell projection, neuron projection
CC       {ECO:0000250|UniProtKB:Q60857}. Note=Could be part of recycling
CC       endosomes (PubMed:16870614). Density of transporter molecules on the
CC       plasma membrane is itself regulated by STX1A (PubMed:11709063). Density
CC       of transporter molecules on the plasma membrane is also regulated by
CC       serotonin (By similarity). Density of transporter molecules seems to be
CC       modulated by ITGAV:ITGB3 (By similarity).
CC       {ECO:0000250|UniProtKB:P31645, ECO:0000250|UniProtKB:Q60857,
CC       ECO:0000269|PubMed:11709063, ECO:0000269|PubMed:16870614}.
CC   -!- TISSUE SPECIFICITY: Expressed in the intestinal crypt epithelial cells
CC       and myenteric neurons of the small intestine (at protein level)
CC       (PubMed:8601815). Expressed in the brain (PubMed:1944572).
CC       {ECO:0000269|PubMed:1944572, ECO:0000269|PubMed:8601815}.
CC   -!- PTM: Phosphorylation at Thr-276 increases 5-HT uptake and is required
CC       for cGMP-mediated SERT regulation. {ECO:0000269|PubMed:17310063}.
CC   -!- MISCELLANEOUS: This protein is the target of psychomotor stimulants
CC       such as amphetamines or cocaine.
CC   -!- SIMILARITY: Belongs to the sodium:neurotransmitter symporter (SNF) (TC
CC       2.A.22) family. SLC6A4 subfamily. {ECO:0000305}.
CC   -!- CAUTION: Reported to be glycosylated with sialylated N-glycans and in
CC       its sialylated form to interact with MYH9 (PubMed:12944413). However,
CC       this publication was retracted due to image duplication in the figures.
CC       {ECO:0000269|PubMed:12944413, ECO:0000305|PubMed:31201245}.
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; X63995; CAA45401.1; -; mRNA.
DR   EMBL; X63253; CAA44913.1; -; mRNA.
DR   EMBL; M79450; AAA42186.1; -; mRNA.
DR   EMBL; Y11024; CAA71909.1; -; mRNA.
DR   PIR; S19585; S19585.
DR   PIR; S30604; S30604.
DR   RefSeq; NP_037166.2; NM_013034.4.
DR   RefSeq; XP_008766172.1; XM_008767950.2.
DR   RefSeq; XP_017452530.1; XM_017597041.1.
DR   RefSeq; XP_017452531.1; XM_017597042.1.
DR   RefSeq; XP_017452532.1; XM_017597043.1.
DR   AlphaFoldDB; P31652; -.
DR   SMR; P31652; -.
DR   BioGRID; 247584; 2.
DR   IntAct; P31652; 1.
DR   STRING; 10116.ENSRNOP00000004717; -.
DR   BindingDB; P31652; -.
DR   ChEMBL; CHEMBL313; -.
DR   DrugCentral; P31652; -.
DR   GuidetoPHARMACOLOGY; 928; -.
DR   GlyCosmos; P31652; 2 sites, No reported glycans.
DR   GlyGen; P31652; 2 sites.
DR   iPTMnet; P31652; -.
DR   PhosphoSitePlus; P31652; -.
DR   SwissPalm; P31652; -.
DR   PaxDb; 10116-ENSRNOP00000004717; -.
DR   Ensembl; ENSRNOT00000004717.7; ENSRNOP00000004717.4; ENSRNOG00000003476.8.
DR   Ensembl; ENSRNOT00055043119; ENSRNOP00055035181; ENSRNOG00055025018.
DR   Ensembl; ENSRNOT00060031180; ENSRNOP00060025278; ENSRNOG00060018174.
DR   GeneID; 25553; -.
DR   KEGG; rno:25553; -.
DR   AGR; RGD:3714; -.
DR   CTD; 6532; -.
DR   RGD; 3714; Slc6a4.
DR   eggNOG; KOG3659; Eukaryota.
DR   GeneTree; ENSGT00940000157855; -.
DR   HOGENOM; CLU_006855_9_0_1; -.
DR   InParanoid; P31652; -.
DR   OMA; GEDCQGN; -.
DR   OrthoDB; 3084493at2759; -.
DR   PhylomeDB; P31652; -.
DR   TreeFam; TF343812; -.
DR   Reactome; R-RNO-380615; Serotonin clearance from the synaptic cleft.
DR   PRO; PR:P31652; -.
DR   Proteomes; UP000002494; Chromosome 10.
DR   Bgee; ENSRNOG00000003476; Expressed in duodenum and 16 other cell types or tissues.
DR   GO; GO:0012505; C:endomembrane system; IDA:UniProtKB.
DR   GO; GO:0010008; C:endosome membrane; IEA:UniProtKB-SubCell.
DR   GO; GO:0005925; C:focal adhesion; ISS:UniProtKB.
DR   GO; GO:0045121; C:membrane raft; ISO:RGD.
DR   GO; GO:0043005; C:neuron projection; IBA:GO_Central.
DR   GO; GO:0005886; C:plasma membrane; IDA:UniProtKB.
DR   GO; GO:0045211; C:postsynaptic membrane; IDA:SynGO.
DR   GO; GO:0042734; C:presynaptic membrane; IDA:SynGO.
DR   GO; GO:0099154; C:serotonergic synapse; IDA:SynGO.
DR   GO; GO:0045202; C:synapse; ISS:UniProtKB.
DR   GO; GO:0051015; F:actin filament binding; IDA:UniProtKB.
DR   GO; GO:0015297; F:antiporter activity; ISO:RGD.
DR   GO; GO:0019811; F:cocaine binding; IMP:RGD.
DR   GO; GO:0042802; F:identical protein binding; IPI:UniProtKB.
DR   GO; GO:0005178; F:integrin binding; ISS:UniProtKB.
DR   GO; GO:0008504; F:monoamine transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0005261; F:monoatomic cation channel activity; IDA:UniProtKB.
DR   GO; GO:0005326; F:neurotransmitter transmembrane transporter activity; ISO:RGD.
DR   GO; GO:0050998; F:nitric-oxide synthase binding; ISO:RGD.
DR   GO; GO:0051378; F:serotonin binding; ISS:UniProtKB.
DR   GO; GO:0005335; F:serotonin:sodium:chloride symporter activity; IDA:UniProtKB.
DR   GO; GO:0031402; F:sodium ion binding; ISS:UniProtKB.
DR   GO; GO:0017075; F:syntaxin-1 binding; IPI:UniProtKB.
DR   GO; GO:0006865; P:amino acid transport; IBA:GO_Central.
DR   GO; GO:0048148; P:behavioral response to cocaine; IMP:RGD.
DR   GO; GO:0048854; P:brain morphogenesis; ISO:RGD.
DR   GO; GO:0071321; P:cellular response to cGMP; IDA:RGD.
DR   GO; GO:0071300; P:cellular response to retinoic acid; IEP:RGD.
DR   GO; GO:0007623; P:circadian rhythm; IMP:RGD.
DR   GO; GO:1990708; P:conditioned place preference; IMP:RGD.
DR   GO; GO:0048484; P:enteric nervous system development; ISO:RGD.
DR   GO; GO:0007626; P:locomotory behavior; NAS:RGD.
DR   GO; GO:0051899; P:membrane depolarization; IDA:UniProtKB.
DR   GO; GO:0007613; P:memory; IMP:RGD.
DR   GO; GO:0015844; P:monoamine transport; ISO:RGD.
DR   GO; GO:0021941; P:negative regulation of cerebellar granule cell precursor proliferation; IMP:RGD.
DR   GO; GO:0045665; P:negative regulation of neuron differentiation; IMP:RGD.
DR   GO; GO:0046621; P:negative regulation of organ growth; ISO:RGD.
DR   GO; GO:0032227; P:negative regulation of synaptic transmission, dopaminergic; IMP:RGD.
DR   GO; GO:0098810; P:neurotransmitter reuptake; ISO:RGD.
DR   GO; GO:0006836; P:neurotransmitter transport; ISO:RGD.
DR   GO; GO:0070527; P:platelet aggregation; ISS:UniProtKB.
DR   GO; GO:0045787; P:positive regulation of cell cycle; ISO:RGD.
DR   GO; GO:0010628; P:positive regulation of gene expression; ISO:RGD.
DR   GO; GO:0014064; P:positive regulation of serotonin secretion; IMP:RGD.
DR   GO; GO:0090067; P:regulation of thalamus size; ISS:UniProtKB.
DR   GO; GO:0032355; P:response to estradiol; IEP:RGD.
DR   GO; GO:0001666; P:response to hypoxia; IEP:RGD.
DR   GO; GO:0007584; P:response to nutrient; IEP:RGD.
DR   GO; GO:0009636; P:response to toxic substance; ISO:RGD.
DR   GO; GO:0009410; P:response to xenobiotic stimulus; IEP:RGD.
DR   GO; GO:0006837; P:serotonin transport; IDA:UniProtKB.
DR   GO; GO:0051610; P:serotonin uptake; IDA:UniProtKB.
DR   GO; GO:0035176; P:social behavior; ISO:RGD.
DR   GO; GO:0035725; P:sodium ion transmembrane transport; IBA:GO_Central.
DR   GO; GO:0042713; P:sperm ejaculation; IMP:RGD.
DR   GO; GO:0042310; P:vasoconstriction; IMP:RGD.
DR   CDD; cd11513; SLC6sbd_SERT; 1.
DR   InterPro; IPR000175; Na/ntran_symport.
DR   InterPro; IPR013086; Na/ntran_symport_serotonin_N.
DR   InterPro; IPR037272; SNS_sf.
DR   NCBIfam; NF037979; Na_transp; 1.
DR   PANTHER; PTHR11616:SF105; SODIUM-DEPENDENT SEROTONIN TRANSPORTER; 1.
DR   PANTHER; PTHR11616; SODIUM/CHLORIDE DEPENDENT TRANSPORTER; 1.
DR   Pfam; PF03491; 5HT_transport_N; 1.
DR   Pfam; PF00209; SNF; 1.
DR   PRINTS; PR01203; 5HTTRANSPORT.
DR   PRINTS; PR00176; NANEUSMPORT.
DR   SUPFAM; SSF161070; SNF-like; 1.
DR   PROSITE; PS00610; NA_NEUROTRAN_SYMP_1; 1.
DR   PROSITE; PS00754; NA_NEUROTRAN_SYMP_2; 1.
DR   PROSITE; PS50267; NA_NEUROTRAN_SYMP_3; 1.
PE   1: Evidence at protein level;
KW   Antiport; Cell junction; Cell membrane; Cell projection; Disulfide bond;
KW   Endosome; Glycoprotein; Membrane; Metal-binding;
KW   Neurotransmitter transport; Phosphoprotein; Reference proteome; Sodium;
KW   Synapse; Transmembrane; Transmembrane helix; Transport.
FT   CHAIN           1..630
FT                   /note="Sodium-dependent serotonin transporter"
FT                   /id="PRO_0000214760"
FT   TOPO_DOM        1..87
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        88..112
FT                   /note="Helical; Name=1"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        113..115
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        116..135
FT                   /note="Helical; Name=2"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        136..160
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        161..186
FT                   /note="Helical; Name=3"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        187..252
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        253..271
FT                   /note="Helical; Name=4"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        272..277
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        278..297
FT                   /note="Helical; Name=5"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        298..324
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        325..347
FT                   /note="Helical; Name=6"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        348..360
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        361..380
FT                   /note="Helical; Name=7"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        381..421
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        422..443
FT                   /note="Helical; Name=8"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        444..463
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        464..483
FT                   /note="Helical; Name=9"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        484..494
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        495..516
FT                   /note="Helical; Name=10"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        517..538
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        539..558
FT                   /note="Helical; Name=11"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        559..574
FT                   /note="Extracellular"
FT                   /evidence="ECO:0000305"
FT   TRANSMEM        575..595
FT                   /note="Helical; Name=12"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   TOPO_DOM        596..630
FT                   /note="Cytoplasmic"
FT                   /evidence="ECO:0000305"
FT   REGION          23..60
FT                   /note="Disordered"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   REGION          616..624
FT                   /note="Interaction with RAB4A"
FT                   /evidence="ECO:0000250"
FT   COMPBIAS        35..60
FT                   /note="Polar residues"
FT                   /evidence="ECO:0000256|SAM:MobiDB-lite"
FT   BINDING         94
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         96
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         97
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         98
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   BINDING         98
FT                   /ligand="serotonin"
FT                   /ligand_id="ChEBI:CHEBI:350546"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   BINDING         101
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         336
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         368
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="2"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         434
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         437
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         438
FT                   /ligand="Na(+)"
FT                   /ligand_id="ChEBI:CHEBI:29101"
FT                   /ligand_label="1"
FT                   /evidence="ECO:0000250|UniProtKB:Q7K4Y6"
FT   BINDING         439
FT                   /ligand="serotonin"
FT                   /ligand_id="ChEBI:CHEBI:350546"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   BINDING         494
FT                   /ligand="serotonin"
FT                   /ligand_id="ChEBI:CHEBI:350546"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   BINDING         495
FT                   /ligand="serotonin"
FT                   /ligand_id="ChEBI:CHEBI:350546"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   BINDING         556
FT                   /ligand="serotonin"
FT                   /ligand_id="ChEBI:CHEBI:350546"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   BINDING         559
FT                   /ligand="serotonin"
FT                   /ligand_id="ChEBI:CHEBI:350546"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   MOD_RES         47
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   MOD_RES         142
FT                   /note="Phosphotyrosine"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   MOD_RES         276
FT                   /note="Phosphothreonine"
FT                   /evidence="ECO:0000269|PubMed:17310063"
FT   CARBOHYD        208
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   CARBOHYD        217
FT                   /note="N-linked (GlcNAc...) asparagine"
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   DISULFID        200..209
FT                   /evidence="ECO:0000250|UniProtKB:P31645"
FT   MUTAGEN         14..23
FT                   /note="ECKDREDCQE->ACKARAACQA: Abolishes the interaction
FT                   with STX1A."
FT                   /evidence="ECO:0000269|PubMed:14642278"
FT   MUTAGEN         101
FT                   /note="N->A: Disrupts chloride ion dependence of serotonin
FT                   transport."
FT                   /evidence="ECO:0000269|PubMed:21730057"
FT   MUTAGEN         109
FT                   /note="C->A: Cocaine is effective at blocking transport."
FT                   /evidence="ECO:0000269|PubMed:10716733"
FT   MUTAGEN         172
FT                   /note="I->C: Cocaine is effective at blocking transport."
FT                   /evidence="ECO:0000269|PubMed:10716733"
FT   MUTAGEN         177
FT                   /note="N->G: Increases channel conductance."
FT                   /evidence="ECO:0000269|PubMed:8968583"
FT   MUTAGEN         277
FT                   /note="S->C: Disrupts chloride ion dependence of serotonin
FT                   transport; when associated with A-101."
FT                   /evidence="ECO:0000269|PubMed:21730057"
FT   MUTAGEN         404
FT                   /note="S->C: Disrupts chloride ion dependence of serotonin
FT                   transport; when associated with A-101."
FT                   /evidence="ECO:0000269|PubMed:21730057"
FT   CONFLICT        415
FT                   /note="A -> G (in Ref. 4; AAA42186)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        533..536
FT                   /note="PGWF -> GMV (in Ref. 4; AAA42186)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        621..630
FT                   /note="PCGDIRMNAV -> RVGHPHECCVTHPGRGHLFPATSLSSEKPTGLLL (in
FT                   Ref. 4; AAA42186)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   630 AA;  70172 MW;  44DA7C5888C403EE CRC64;
     METTPLNSQK VLSECKDRED CQENGVLQKG VPTTADRAEP SQISNGYSAV PSTSAGDEAS
     HSIPAATTTL VAEIRQGERE TWGKKMDFLL SVIGYAVDLG NIWRFPYICY QNGGGAFLLP
     YTIMAIFGGI PLFYMELALG QYHRNGCISI WRKICPIFKG IGYAICIIAF YIASYYNTII
     AWALYYLISS LTDRLPWTSC TNSWNTGNCT NYFAQDNITW TLHSTSPAEE FYLRHVLQIH
     QSKGLQDLGT ISWQLTLCIV LIFTVIYFSI WKGVKTSGKV VWVTATFPYI VLSVLLVRGA
     TLPGAWRGVV FYLKPNWQKL LETGVWVDAA AQIFFSLGPG FGVLLAFASY NKFNNNCYQD
     ALVTSVVNCM TSFVSGFVIF TVLGYMAEMR NEDVSEVAKD AGPSLLFITY AEAIANMPAS
     TFFAIIFFLM LITLGLDSTF AGLEGVITAV LDEFPHIWAK RREWFVLIVV ITCVLGSLLT
     LTSGGAYVVT LLEEYATGPA VLTVALIEAV AVSWFYGITQ FCSDVKEMLG FSPGWFWRIC
     WVAISPLFLL FIICSFLMSP PQLRLFQYNY PHWSIVLGYC IGMSSVICIP TYIIYRLIST
     PGTLKERIIK SITPETPTEI PCGDIRMNAV
//
